SCHEMBL8285358

SCHEMBL8285358

Cc1cc2c(c(NC(=O)c3ccccc3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
POLB P06746 2/20 0.43
ADORA3 P0DMS8 5/20 0.41
ADORA1 P30542 2/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
KDR P35968 2/20 0.41
RAB9A P51151 3/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.40
ADORA2A P29274 2/20 0.39
GFER P55789 1/20 0.39
PDE11A Q9HCR9 1/20 0.38
PKM P14618 1/20 0.38
NPC1 O15118 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285359 0.89 KDM4E (0.47) GAAADORA3MAPTKDM4ERAB9A
SCHEMBL8287944 0.87 GAA (0.43) GAAMAPTKDM4ERAB9AHTT
SCHEMBL8287996 0.84 MAPT (0.43) GAAPOLBMAPTKDM4ERAB9A
SCHEMBL8358804 0.84 MAT2A (0.41) GAAMAPTKDM4EHTTSMN1; SMN2
SCHEMBL8287217 0.83 RIPK1 (0.43) MAPTKDM4ERAB9AHTTSMN1; SMN2
SCHEMBL8286535 0.83 OPRK1 (0.45) GAAADORA3ADORA1MAPTSMN1; SMN2
SCHEMBL5871645 0.82 GAA (0.42) GAAMAPTKDM4ERAB9AHTT
SCHEMBL8286452 0.82 PDE11A (0.44) GAAPOLBMAPTKDM4EKDR
SCHEMBL8286573 0.82 GAA (0.42) GAAPOLBMAPTKDM4ERAB9A
SCHEMBL5872108 0.81 GAA (0.44) GAAMAPTKDM4ERAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed